Vertebral Fragility Fracture and Osteoporosis among children exposed to glucocorticoids - NI

Department of Health Research0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年8月21日

试验速览

暂无简介。

•Children with the following three diseases, who are either newly diagnosed or on follow up will be recruited:
•1.Rheumatic Disease (RD):
•Children between 1 month to 18 years with diagnosis of Juvenile Idiopathic Arthritis (JIA), Systemic Lupus Erythematosus (SLE). (13)(14).
•2.Nephrotic syndrome (NS):
•Children between 1 month to 18 years with diagnosis of Nephrotic syndrome (first episode, relapse, steroid dependent, steroid resistant). (15).
•3.Acute Lymphoblastic leukemia (ALL):
•Children between 1 month to 18 years with diagnosis of Acute Lymphoblastic Leukemia (16).
•Newly diagnosed cases of all three diseases will be included within 14 days of diagnosis. The follow up cases will be included if they have received at least 3 months of daily or alternate day steroid therapy, more than physiological replacement dose ( >2 mg/m2/day prednisolone equivalent) in last 6 months.

发起方

Department of Health Research